Zyon Ayni: “The Company is Preparing to Submit Emergency Approval Requests”
Codivir, a medicine used to treat HIV that also has a direct antiviral effect on coronavirus, was featured in an article published in the Jerusalem Post. The goal, according to Zyon Ayni, CEO and founder of Code Pharma, is to complete the study in three to six months and then file for emergency use authorization […]
Zyon Ayni: “The Company is Preparing to Submit Emergency Approval Requests” Read More »
